Global Dengue — CDC Level 1 Watch (Published 10 Nov 2026)
The U.S. Centers for Disease Control and Prevention has maintained a Level 1 ("Practice Usual Precautions") Watch for dengue in multiple regions. Dengue is transmitted by Aedes mosquitoes that bite primarily during daylight hours, and transmission is year-round in many tropical and subtropical areas, with larger outbreaks typically recurring every 2–5 years.
Destinations named in the notice
The CDC country listings include: Colombia, Vietnam, Maldives, Bolivia, Cambodia, Kenya, Malaysia, Sri Lanka, Bangladesh, Costa Rica, Marshall Islands, Vanuatu, Cuba, Ecuador (including the Galápagos Islands), Panama, Chad, and Peru. Listings are revised as surveillance data change, so travelers should re-check the destination page close to departure.
What the public-health guidance says
- Prevent mosquito bites throughout the day: EPA-registered repellents, long sleeves and trousers, permethrin-treated clothing and gear, and air-conditioned or screened accommodation.
- Recognize illness: dengue commonly presents with fever, headache, retro-orbital pain, muscle and joint pain, nausea, and rash. Warning signs for severe disease — persistent vomiting, severe abdominal pain, bleeding from the gums or nose, or marked lethargy — require urgent medical evaluation.
- Timing matters: fever within two weeks of travel should prompt disclosure of the full travel itinerary to a healthcare professional, as dengue overlaps clinically with malaria, chikungunya, and Zika.
- Vaccination: dengue vaccines exist but have narrow, country-specific eligibility criteria (including prior-infection and age requirements) and are not broadly available to travelers. Eligibility is an individual clinical determination.
Pharmacist's note: From a pharmaceutical-sciences standpoint, the most useful preparation is reviewing your own medication list before departure. Published public-health materials highlight that aspirin and NSAIDs are generally avoided in suspected dengue because of platelet and bleeding concerns — relevant if you routinely use these agents or anticoagulants. Also consider that repellent efficacy depends on correct application interval and concentration, not brand, and that sunscreen-plus-repellent layering order affects performance. Discuss any changes to prescribed therapy, and any analgesic or antipyretic selection, with your own clinician or pharmacist rather than self-adjusting while abroad.
This summary is public-information only and is not individualized medical advice.